Yüklüyor......
The pharmacokinetics and dosing of oral 4‐methylumbelliferone for inhibition of hyaluronan synthesis in mice
Recently, there has been considerable interest in using 4‐methylumbelliferone (4‐MU) to inhibit hyaluronan (HA) synthesis in mouse models of cancer, autoimmunity and a variety of other inflammatory disorders where HA has been implicated in disease pathogenesis. In order to facilitate future studies...
Kaydedildi:
| Yayımlandı: | Clin Exp Immunol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4991518/ https://ncbi.nlm.nih.gov/pubmed/27218304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12815 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|